Training Policy for IBC
A. Purpose The Institutional Biosafety Committee (IBC) seeks to ensure the qualifications of all IBC personnel who handle rDNA and biohazardous materials to enable them to carry out their responsibilities in compliance with applicable guidelines and regulations. IBC must consider the training and experience of personnel involved in conducting research as part of its protocol […]
Research Occupational Health Program
BU’s Research Occupational Health Program (ROHP) focuses on the health, wellness, and safety of the […]
Material Transfer Agreements
Material transfer agreements (MTAs) are agreements that establish the terms and conditions upon which proprietary materials are transferred by BU to outside parties, or received by BU from outside parties, for use by designated persons in specified and approved research protocols. Why are MTAs important? MTAs protect the intellectual property rights of Boston University, Boston […]
Identifying and Addressing Dual Use Research of Concern
There is no excerpt because this is a protected post.
Biological Research and Export Controls
Export controls are federal government regulations that restrict the transfer of certain materials, technology or software abroad or to non-US Persons in the United States. There are two sets of export controls that govern biological research and shipments: the Export Administration Regulations (EAR) that govern dual-use items, technologies and software with commercial and military applications […]
Training and Health Clearance Requirements
Training and Health Clearance Requirements Original Date Approved: 2011 Revised: 5/17/16 Next Review Date: May 2019 Purpose Boston University (BU) is committed to observing federal, state, and local regulations and the National Institute of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The purpose of this policy is to set forth […]
Inactivated Biological Sample Use
The purpose of the Inactivated Biological Samples Use policy is to develop a process whereby samples generated as BSL-3 and BSL-4 can be used safely at lower biosafety levels. Inactivation of biological samples renders them non-infectious and therefore they can be handled as Risk Group 1 (RG1) agent under BSL-1 conditions. This policy requires that […]
Chapter 7: Decontamination and Sterilization
Definitions Decontamination is a process or treatment that renders a device, instrument, or work surface safe to handle. A decontamination procedure can range from sterilization by autoclave or ethylene oxide to simple cleaning with soap and water. Sterilization, disinfection, and antisepsis are all forms of decontamination. Sterilization is the use of a physical or chemical […]
Chapter 9: Biohazardous and Medical Waste Disposal
In the Commonwealth of Massachusetts, biohazardous waste is governed by the Department of Public Health regulation 105 CMR 480, “Storage and Disposal of Infectious or Physically Dangerous Medical or Biological Waste, State Sanitary Code Chapter VIII.” Boston University has biological waste management guidance documents for each campus which are reviewed annually and posted on the […]
Chapter 11: Transportation of Biological Materials
Training is required prior to shipping of materials off campus. This does not count as training. The packaging and transportation of biological materials are subject to strict local, state, federal, and international regulations. This is particularly so if the material is transported through the “public domain,” namely, those roadways, airways, and sea lanes accessible to […]